BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6604576)

  • 1. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.
    Hamilton TC; Young RC; McKoy WM; Grotzinger KR; Green JA; Chu EW; Whang-Peng J; Rogan AM; Green WR; Ozols RF
    Cancer Res; 1983 Nov; 43(11):5379-89. PubMed ID: 6604576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice.
    Hamilton TC; Young RC; Louie KG; Behrens BC; McKoy WM; Grotzinger KR; Ozols RF
    Cancer Res; 1984 Nov; 44(11):5286-90. PubMed ID: 6333272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormone receptor characterization of several histologic variants of a rat prostatic adenocarcinoma.
    Markland FS; Chopp RT; Cosgrove MD; Howard EB
    J Supramol Struct; 1978; 9(4):509-24. PubMed ID: 750763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone receptor studies in melanoma model systems.
    Markland FS; Horn D
    J Supramol Struct; 1980; 13(1):35-46. PubMed ID: 7442253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
    Pollack A; Irvin GL; Block NL; Lipton RM; Stover BJ; Claflin AJ
    Cancer Res; 1982 Jun; 42(6):2184-90. PubMed ID: 7074599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.
    Wilson AP
    J Natl Cancer Inst; 1984 Mar; 72(3):513-21. PubMed ID: 6583437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a human ovarian carcinoma cell line: UCI 101.
    Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
    Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LNCaP model of human prostatic carcinoma.
    Horoszewicz JS; Leong SS; Kawinski E; Karr JP; Rosenthal H; Chu TM; Mirand EA; Murphy GP
    Cancer Res; 1983 Apr; 43(4):1809-18. PubMed ID: 6831420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of the growth rate of human breast cancer cells by antiandrogen followed by chemotherapy.
    Alama A; Miglietta L; Favoni RE; Barbieri F; Ravera F; Fazzuoli L; Nicolo G; Nicolin A
    Anticancer Res; 1990; 10(3):853-8. PubMed ID: 2142397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of steroid receptors in human soft tissue sarcomas of diverse histological origin.
    Chaudhuri PK; Walker MJ; Beattie CW; Das Gupta TK
    Cancer Res; 1980 Mar; 40(3):861-5. PubMed ID: 6258789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor predominance in human ovarian carcinoma.
    Kühnel R; de Graaff J; Rao BR; Stolk JG
    J Steroid Biochem; 1987 Mar; 26(3):393-7. PubMed ID: 3495702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endometrial carcinoma cell cultures by a synthetic androgen.
    Centola GM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6264-7. PubMed ID: 3877566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Density-dependent induction of apoptosis by transforming growth factor-beta 1 in a human ovarian carcinoma cell line.
    Mathieu C; Jozan S; Mazars P; Côme MG; Moisand A; Valette A
    Exp Cell Res; 1995 Jan; 216(1):13-20. PubMed ID: 7813613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sex and gonadectomy on sex steroid receptors in rat adrenal gland.
    Calandra RS; Lüthy I; Finocchiaro L; Terrab RC
    J Steroid Biochem; 1980 Nov; 13(11):1331-5. PubMed ID: 6969821
    [No Abstract]   [Full Text] [Related]  

  • 18. Gradient centrifugation analysis of steroid-hormone binding in human malignant melanoma.
    Bojar H; Stuhldreier B; Becher R; Koldovsky U; Goerz G; Merk H; Staib W
    Anticancer Res; 1982; 2(4):245-9. PubMed ID: 7149655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion.
    Shapiro E; Lippman ME
    J Steroid Biochem; 1985 Jan; 22(1):15-20. PubMed ID: 3871880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1 alpha,25-dihydroxycholecalciferol receptors.
    Liesegang P; Romalo G; Sudmann M; Wolf L; Schweikert HU
    J Androl; 1994; 15(3):194-9. PubMed ID: 7928659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.